Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

MERCURY LABORATORIES LTD.

NSE : NABSE : 538964ISIN CODE : INE947G01011Industry : Pharmaceuticals & DrugsHouse : Private

BSE888.0031.75 (+3.71 %)

PREV CLOSE ( ) 856.25

OPEN PRICE ( ) 856.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 39

TODAY'S LOW / HIGH ( )856.25 888.00

52 WK LOW / HIGH ( ) 7361190

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 12-02 1982

Management Info

Bharat Mehta - Chairman Rajendra R Shah - Managing Director

Registered Office

Address 18, Shreeji Bhuvan,51, Mangaldas Road,Princess Street,
Mumbai,
Maharashtra-400002

Phone 022 66372841

Email mllbom@mtnl.net.in / mllbrd@mercurylabs.com / secretarial@mercurylabs.com

Website www.mercurylabs.com

Registrars Details

MUFG Intime India Pvt Ltd.

Geetakunu, 1, Bhakti Nagar Society,Behind ABS Tower,Old Padra Road,Vadodara

Listing : BSE, OTCEI

NEWS

19Jul Mercury Laboratories informs about pre
Mercury Laboratories has informed that it enclosed newspaper copies of p..

07Jul Mercury Laboratories informs about com
Mercury Laboratories has enclosed a certificate under regulation 74(5) o..

17May Mercury Laboratories informs about ann
Mercury Laboratories has informed that it enclosed the Annual Secretaria..

08May Mercury Laboratories informs about bo
Pursuant to Regulation 29 of the SEBI (Listing Obligations & Disclos..

08May Mercury Laboratories informs about boa
Mercury Laboratories has informed that the meeting of the Board of Direc..

Financials

Rs. in Millions

	QTR Mar 25	ANNUAL 25
Net Profit	11.1	31.4500000000001
Gross Profit	14.47	46.6100000000001
Operating Profit	23.08	80.8500000000001
Net Sales	206.59	751.01

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Blue Jet Healthcare (BSE) 1012.00 (4.21%)	M.Cap ( in Cr)17554.70
Jubilant Pharmova (BSE) 1234.90 (2.87%)	M.Cap ( in Cr)19669.63
Sanjivani Paranteral (BSE) 247.40 (11.39%)	M.Cap ( in Cr)303.91
Abbott India (BSE) 34148.85 (0.06%)	M.Cap ( in Cr)72563.92
BDH Inds (BSE) 294.00 (7.14%)	M.Cap ( in Cr)169.26

Shareholding Pattern

	PROMOTERS	73.66%
	NON-INSTITUTION	26.34%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

MERCURY LABORATORIES LTD.